CMS Released Preliminary 2027 Medicare Lab Rates
The federal agency has proposed new laboratory payment rates to align Medicare pricing with private sector market costs.
Updated on Sept. 21, 2026 in Healthcare
Live Poll
Should Medicare align its payment rates for laboratory tests with those paid by private insurers?
The Centers for Medicare and Medicaid Services (CMS) has unveiled preliminary 2027 payment rates for laboratory services. The move aims to realign Medicare pricing with private sector market rates, addressing a gap where Medicare has historically paid 16% more for these services.
Why it matters
Aligning these rates is projected to save taxpayers $1 billion annually by reducing excessive spending on laboratory testing. The update follows a federal mandate requiring periodic revisions to laboratory payment schedules to reflect current market realities.
Medicare has historically paid 16% more for laboratory services than private insurers. The adjustment is expected to result in $1 billion in annual taxpayer savings as rates are phased in through 2029.
The players
Centers for Medicare and Medicaid Services
This federal agency within the United States Department of Health and Human Services administers the Medicare program and coordinates the Medicaid and Children's Health Insurance Programs.
The details
CMS collected updated private payor data from laboratories under authority granted by the Consolidated Appropriations Act, 2026. Reductions in Medicare payments for clinical diagnostic laboratory tests will be phased in annually at a maximum of 15% per test through 2029.
Timeline
Congress created the laboratory payment rate update process in 2014.
CMS held public meetings on laboratory test pricing on September 15 and 16, 2026.
The preliminary 2027 laboratory payment rates were released on September 21, 2026.
CMS expects to finalize the laboratory payment rates in November 2026.
The final laboratory payment rates will take effect on January 1, 2027.
Market Landscape
This adjustment follows the regulatory framework established by the Consolidated Appropriations Act, 2026. The move significantly impacts the competitive environment for diagnostic laboratories by forcing alignment with private sector fee structures.
While these rate adjustments primarily target laboratory reimbursement structures, they are designed to curb broader federal healthcare spending. Patients should monitor whether these changes influence the accessibility or pricing of diagnostic tests at their local healthcare facilities.
The takeaway
The federal effort to realign laboratory pricing reflects a long-term goal of improving Medicare efficiency. Providers and industry stakeholders should prepare for continued annual payment adjustments through 2029 as the government phases in these market-based rates.
What happens next
The public comment period for the preliminary 2027 rates is open for 30 days starting from September 21, 2026. CMS is scheduled to finalize these payment rates in November 2026, ahead of the January 1, 2027 implementation date.
Further reading
For more context on ongoing regulatory shifts, visit the Healthcare section.
More information
To review the current proposals, view preliminary clinical laboratory fee schedule on the official CMS portal.
Live Poll
Should Medicare align its payment rates for laboratory tests with those paid by private insurers?
